Alto Neuroscience (ANRO) Total Current Liabilities (2023 - 2026)

Alto Neuroscience (ANRO) has 4 years of Total Current Liabilities data on file, last reported at $13.1 million in Q1 2026.

• For the quarter ending Q1 2026, Total Current Liabilities rose 80.72% year-over-year to $13.1 million; the trailing twelve-month figure through Mar 2026 stood at $13.1 million (up 80.72% YoY), and the FY2025 full-year result was $11.3 million, up 13.16% from the prior year.
• Total Current Liabilities grew to $13.1 million in Q1 2026, from $11.3 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $14.0 million in Q3 2024 to a low of $5.6 million in Q4 2023.
• A 4-year average of $9.6 million and a median of $9.4 million in 2024 frame the typical range for Total Current Liabilities.
• Across the five-year window, Total Current Liabilities tumbled 35.46% in 2025 and jumped 80.72% in 2026, its largest moves.
• Tracing ANRO's Total Current Liabilities over 4 years: stood at $5.6 million in 2023, then jumped by 78.4% to $10.0 million in 2024, then gained by 13.16% to $11.3 million in 2025, then climbed by 15.81% to $13.1 million in 2026.
• Business Quant data shows ANRO's Total Current Liabilities at $13.1 million in Q1 2026, $11.3 million in Q4 2025, and $9.0 million in Q3 2025.